Cellular trafficking is only recently identified as a site for therapeutic intervention. This book provides up to date information on the mechanism for exploiting this area for drug development as well as a clear understanding of the individual components of cellular trafficking. The authors are experts in their areas and the book features tables and figures that enable comparison and clear understanding.

1. Intracellular trafficking of gonadotropin receptors in health and disease

2. Investigating internalization and intracellular trafficking of GPCRs
3. Pharmacological chaperones as potential therapeutic strategies for misfolded mutant vasopressin receptors
4. Targeting of disordered proteins by small molecules in neurodegenerative diseases
5. Pharmacoperones for misfolded gonadotropin receptors
6. Pharmacological chaperones: Beyond conformational disorders
7. Natural (and unnatural) small molecules as pharmacological chaperones and inhibitors in cancer
8. Heritable skeletal disorders arising from defects in processing and transport of Type I procollagen from the ER: perspectives on possible therapeutic approaches
9. Conserved oligomeric Golgi and neuronal vesicular trafficking
10. SLC6 transporter folding diseases and pharmacochaperoning
11. The molecular physiopathogenesis of islet amyloidosis
12. Folding defects leading to primary hyperoxaluria
13. Potentialpharmacological chaperones for cystathionine beta-synthase-deficient homocystinuria.